Symrise Unveils Cellexora™ MD: A Breakthrough Healthspan Ingredient for Premium Skincare
- ial
- Apr 14
- 1 min read
Symrise has launched Cellexora™ MD, a pioneering plant-derived cosmetic ingredient designed to support long-term skin health, regeneration and vitality in premium skincare formulations. Sourced from upcycled organic Italian apple side streams, the white, odourless powder consists of true extracellular vesicles (exosomes) — biological messengers that facilitate communication between skin cells such as keratinocytes, fibroblasts and macrophages.
This innovative ingredient enters the market via Symrise’s Care & Wellness portfolio, combining scientific rigour with sustainability credentials, including 100 % natural origin content and ISO 16128-2 compliance. Clinical data suggest that Cellexora™ MD can improve collagen production, enhance firmness, elasticity and resilience, and reduce signs of ageing such as wrinkle length, depth and volume within 30 days of use, offering measurable benefits beyond surface correction by addressing the underlying drivers of skin ageing. Its high-water solubility and formulation flexibility make it easy for cosmetic formulators to integrate into a wide range of skincare products.
By focusing on deep biological function and regenerative performance, Symrise aims to meet growing consumer demand for efficacy, transparency and sustainable sourcing in beauty solutions, positioning Cellexora™ MD as a new benchmark in healthspan-driven skincare innovation. Symrise will showcase the ingredient at in-cosmetics Global 2026 in Paris.
Source: Symrise



